Matthew Stanton, CFA
Stock Analyst at Jefferies
(2.33)
# 3,079
Out of 5,060 analysts
22
Total ratings
75%
Success rate
5.2%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton, CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Initiated: Hold | $150 | $155.65 | -3.63% | 1 | Oct 8, 2026 | |
| TKNO Alpha Teknova | Initiated Coverage: Buy | $9 | $8.71 | +3.33% | 1 | Sep 17, 2026 | |
| CYRX Cryoport | Reiterated: Hold | $9.5 → $13 | $17.35 | -25.07% | 6 | Jun 8, 2026 | |
| RGEN Repligen | Reiterated: Hold | $135 → $142 | $167.22 | -15.08% | 7 | May 5, 2026 | |
| AZTA Azenta | Reiterated: Buy | $42 → $35 | $35.89 | -2.48% | 5 | Apr 1, 2026 | |
| MRVI Maravai LifeSciences Holdings | Reiterated: Buy | $10 | $7.43 | n/a | 1 | Mar 18, 2025 | |
| LAB Standard BioTools | Initiated Coverage: Buy | $3.25 | $0.6787 | n/a | 1 | Apr 4, 2024 |
Twist Bioscience
Oct 8, 2026
Initiated: Hold
Price Target: $150
Current: $155.65
Upside: -3.63%
Alpha Teknova
Sep 17, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $8.71
Upside: +3.33%
Cryoport
Jun 8, 2026
Reiterated: Hold
Price Target: $9.5 → $13
Current: $17.35
Upside: -25.07%
Repligen
May 5, 2026
Reiterated: Hold
Price Target: $135 → $142
Current: $167.22
Upside: -15.08%
Azenta
Apr 1, 2026
Reiterated: Buy
Price Target: $42 → $35
Current: $35.89
Upside: -2.48%
Maravai LifeSciences Holdings
Mar 18, 2025
Reiterated: Buy
Price Target: $10
Current: $7.43
Upside: n/a
Standard BioTools
Apr 4, 2024
Initiated Coverage: Buy
Price Target: $3.25
Current: $0.6787
Upside: n/a